Debra Liebert

No open positions remaining

Net worth: 34 180 $ as of 30/07/2026

69 year

84 connections

Health Technology

Consumer Services

Commercial Services

Profile

Debra K.
Liebert is the founder of Calixa Therapeutics, Inc., Nanothera Corp., Sonexa Therapeutics, Inc., and Merada Therapeutics, Inc. She previously worked as the Executive Director of New Product Management at CancerVax Corp.
and as the Managing Director at Domain Associates LLC.
From 2015 to 2024, she served as an Independent Non-Executive Director at Milestone Pharmaceuticals, Inc. Prior to that, she held the position of Vice President of Corporate Development at both Trega Biosciences, Inc. and LPL Technologies, Inc. Ms. Liebert obtained an MBA from the University of California, Los Angeles in 2000.
She also holds an undergraduate degree from Clarion University of Pennsylvania, conferred in 1978, and a graduate degree from Duquesne University of The Holy Spirit, conferred in 1981.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
MILESTONE PHARMACEUTICALS, INC. 0.02%	10/07/2025	30,793 ( 0.02% )	34 180 $	30/07/2026

Former positions of Debra Liebert

Companies	Position	End
MILESTONE PHARMACEUTICALS INC.	Director/Board Member	27/08/2024
Merada Therapeutics, Inc.	Founder	-
Sonexa Therapeutics, Inc. Sonexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drug treatments for Alzheimer's disease and related disorders	Founder	-
Nanothera Corp.	Founder	-
Calixa Therapeutics, Inc. Calixa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes hospital-based anti-infective therapies	Founder	-

See the detail of Debra Liebert's experience

Training of Debra Liebert

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Debra Liebert's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	12
Trega Biosciences, Inc. Trega Biosciences, Inc. BiotechnologyHealth Technology Provides identification and early stage development of novel and small moelcule drug therapies	Health Technology
CancerVax Corp. CancerVax Corp. Miscellaneous Commercial ServicesCommercial Services Researches and develops products for the prevention, treatment, and control of cancer	Commercial Services
Milestone Pharmaceuticals, Inc. Milestone Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures cardiovascular medicines	Health Technology
Calixa Therapeutics, Inc. Calixa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes hospital-based anti-infective therapies	Health Technology
Nanothera Corp.
Domain Associates LLC Domain Associates LLC Investment ManagersFinance Domain Associates invests in both private and public companies located in the United States. The firm focuses on pharmaceuticals, diagnostics and medical device sectors. It provides financing for seed, early and late stage capital requirements. It takes a seat on the board of directors.	Finance
University of California, Los Angeles University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Clarion University of Pennsylvania Clarion University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Duquesne University of The Holy Spirit Duquesne University of The Holy Spirit Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Sonexa Therapeutics, Inc. Sonexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drug treatments for Alzheimer's disease and related disorders	Health Technology
LPL Technologies, Inc. LPL Technologies, Inc. Medical/Nursing ServicesHealth Services Develops diagnostic blood tests for gynecological cancers	Health Services
Merada Therapeutics, Inc.